Calvin Sandra
Insider CIK 1882909 · TVTX VP, Corp Controller and CAO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-15 | 2026-09-17 | 1,250 | — | $0 | 3,750 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-15 | 2026-09-17 | 2,500 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-15 | 2026-09-17 | 1,625 | — | $0 | 17,875 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-15 | 2026-09-17 | 1,625 | $20.46 | $33.2K | 47,728 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 800 | $62.85 | $50.3K | 42,653 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 4,275 | $62.14 | $265.6K | 43,453 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 300 | $63.66 | $19.1K | 42,353 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-15 | 2026-09-17 | 1,250 | $22.40 | $28.0K | 46,103 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-15 | 2026-09-17 | 2,500 | $27.50 | $68.8K | 44,853 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-15 | 2026-09-17 | 1,625 | — | $0 | 17,875 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-15 | 2026-09-17 | 1,250 | — | $0 | 3,750 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-15 | 2026-09-17 | 2,500 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 300 | $63.66 | $19.1K | 42,353 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 800 | $62.85 | $50.3K | 42,653 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 4,275 | $62.13 | $265.6K | 43,453 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-15 | 2026-09-17 | 1,625 | $20.46 | $33.2K | 47,728 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-15 | 2026-09-17 | 1,250 | $22.40 | $28.0K | 46,103 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-15 | 2026-09-17 | 2,500 | $27.50 | $68.8K | 44,853 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-04-14 | 2026-04-16 | 6,500 | — | $0 | 19,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-04-14 | 2026-04-16 | 6,250 | — | $0 | 12,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-04-14 | 2026-04-16 | 2,500 | — | $0 | 5,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-04-14 | 2026-04-16 | 21,977 | $41.07 | $902.6K | 42,353 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-04-14 | 2026-04-16 | 6,500 | $20.46 | $133.0K | 64,330 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-04-14 | 2026-04-16 | 2,500 | $22.40 | $56.0K | 51,580 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-04-14 | 2026-04-16 | 6,250 | $8.93 | $55.8K | 57,830 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-02-03 | 2026-02-03 | 4,333 | $32.12 | $139.2K | 49,080 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2026-01-31 | 2026-02-03 | 20,160 | — | $0 | 20,160 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2026-01-31 | 2026-02-03 | 15,180 | — | $0 | 53,413 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-12-24 | 2025-12-29 | 7,402 | $40.00 | $296.1K | 38,233 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-12-15 | 2025-12-16 | 2,910 | $36.00 | $104.8K | 45,635 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-11-04 | 2025-11-06 | 6,250 | — | $0 | 18,750 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-11-04 | 2025-11-06 | 10,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-11-04 | 2025-11-06 | 17,500 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-11-04 | 2025-11-06 | 15,000 | — | $0 | 2,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-11-04 | 2025-11-06 | 12,500 | — | $0 | 7,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-11-04 | 2025-11-06 | 12,500 | $22.40 | $280.0K | 109,410 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-11-04 | 2025-11-06 | 15,000 | $27.50 | $412.5K | 96,910 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-11-04 | 2025-11-06 | 17,500 | $26.88 | $470.4K | 81,910 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-11-04 | 2025-11-06 | 10,000 | $25.25 | $252.5K | 64,410 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-11-04 | 2025-11-06 | 67,115 | $36.00 | $2.42M | 48,545 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-11-04 | 2025-11-06 | 6,250 | $8.93 | $55.8K | 115,660 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-02-11 | 2025-02-12 | 10,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-02-11 | 2025-02-12 | 15,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-02-11 | 2025-02-12 | 10,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-02-11 | 2025-02-12 | 10,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-02-11 | 2025-02-12 | 10,000 | $17.96 | $179.6K | 73,654 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-02-11 | 2025-02-12 | 15,000 | $25.00 | $375.0K | 63,654 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-02-11 | 2025-02-12 | 15,000 | $15.46 | $231.9K | 78,654 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-02-11 | 2025-02-12 | 10,000 | $25.00 | $250.0K | 63,654 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-02-11 | 2025-02-12 | 9,244 | $25.00 | $231.1K | 54,410 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-02-11 | 2025-02-12 | 10,000 | $25.00 | $250.0K | 63,654 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-02-11 | 2025-02-12 | 10,000 | $17.44 | $174.4K | 73,654 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-02-11 | 2025-02-12 | 10,000 | $25.00 | $250.0K | 63,654 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-02-11 | 2025-02-12 | 10,000 | $16.23 | $162.3K | 73,654 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-02-03 | 2025-02-04 | 3,348 | $20.12 | $67.4K | 63,654 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2025-01-31 | 2025-02-04 | 26,000 | — | $0 | 26,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2025-01-31 | 2025-02-04 | 13,000 | — | $0 | 67,002 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-01-22 | 2025-01-23 | 925 | $18.94 | $17.5K | 54,002 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2024-12-26 | 2024-12-27 | 15,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-12-26 | 2024-12-27 | 15,000 | $17.22 | $258.3K | 54,927 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2024-12-26 | 2024-12-27 | 15,000 | $12.67 | $190.1K | 69,927 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2024-11-25 | 2024-11-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-11-25 | 2024-11-25 | 12,090 | $18.30 | $221.2K | 54,927 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2024-11-25 | 2024-11-25 | 15,000 | $12.67 | $190.1K | 67,017 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-02-01 | 2024-02-02 | 2,820 | $8.53 | $24.1K | 52,017 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2024-01-31 | 2024-02-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2024-01-31 | 2024-02-02 | 1,000 | — | $0 | 54,837 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2024-01-31 | 2024-02-02 | 12,500 | — | $0 | 53,837 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-01-23 | 2024-01-25 | 910 | $9.07 | $8.3K | 41,337 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-05-11 | 2023-05-12 | 122 | $16.12 | $2.0K | 42,247 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-05-10 | 2023-05-12 | 436 | $16.59 | $7.2K | 42,369 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-02-02 | 2023-02-02 | 360 | $22.42 | $8.1K | 42,805 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-02-01 | 2023-02-02 | 1,671 | $21.75 | $36.3K | 43,165 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2023-01-31 | 2023-02-02 | 10,000 | — | $0 | 44,836 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-01-25 | 2023-01-26 | 192 | $21.63 | $4.2K | 34,836 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-01-24 | 2023-01-26 | 905 | $21.90 | $19.8K | 35,028 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-09-13 | 2022-09-15 | 349 | $28.00 | $9.8K | 35,933 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-05-11 | 2022-05-12 | 445 | $21.92 | $9.8K | 35,733 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-05-10 | 2022-05-12 | 436 | $21.51 | $9.4K | 36,178 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2022-01-31 | 2022-02-02 | 17,500 | — | $0 | 17,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-01-31 | 2022-02-02 | 798 | $26.51 | $21.2K | 36,614 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2022-01-31 | 2022-02-02 | 8,750 | — | $0 | 37,412 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-01-24 | 2022-01-26 | 934 | $24.58 | $23.0K | 28,662 | SEC↗ |